Material Technologies Facilitating Targeted Drug Delivery
Nanomaterials are Gaining Research Focus for Targeted Drug Delivery
16-Jun-2020
Global
Technology Research
D956-01-00-00-00
HC03300-GL-TR_24480
Targeted drug delivery is gaining traction owing toward significant demand for improvement in the drug delivery efficiency as well as the need to mitigate potential side-effects, which can occur due to drug accumulation. The concept of targeted drug delivery is not new, the technology started gaining pace with the advent of nanotechnology and biocompatible materials. Targeted drug delivery is expected to have a high impact owing to its high adoption potential and its non-interference with non-target organs.
This research service titled, “Material Technologies Facilitating Targeted Drug Delivery,” provides an understanding of various types of emerging drug delivery materials, with specific focus on nanomaterials such as quantum dots (QDs), CNTs, nanostructured lipids, hydrogels, liposomes and dendrimers.
This research service describes the material capabilities, advantages of the material, key participants and R&D initiatives for each material. Additionally, it also captures the funding received by each material in the span of 2015-2019 and the potential growth opportunities for drug delivery materials
1.1. Research Scope
1.2 Key Findings
1.3 Research Methodology
2.1 Targeted Drug Delivery is Gaining Focus as a Primary Mode of Drug Delivery for Terminal Illnesses
2.2 Varied Materials are Being Considered for Targeted Drug Delivery
3.1.1 Quantum Dots Will Have a High Adoption Potential Due to Their Tunable Characteristics
3.1.2 The US is Observed to Have the Highest Patent Application Share in QD Globally
3.1.3 China Has the Highest Research Outputs for Drug Delivery Using Quantum Dots
3.1.4 Quantum Dots can Find Significant Adoption for Cell Proliferation Therapies
3.1.5 Graphene Flagship Program Plays a Pivotal Role in Development of Quantum Dots in Europe
3.2.1 CNT-based Drug Delivery Systems Will Improve pH Dependent Drug Release
3.2.2 Higher Number of PCT Applications Will Mean Broader Adoption Potential for CNT
3.2.3 Research Publications are Spread Across Regions
3.2.4 National Natural Science Foundation of China Emerges as a key Funding Agency Focusing on Regional and Collaborative Projects Across the Globe
3.2.5 Research on Functionalization of CNTs to Enhance Their Effectiveness is Gaining Traction
3.3.1 Nanostructured Lipids Will Improve Drug Delivery at Tissue Level
3.3.2 Steady Growth in Research Publications for Nanostructured Lipids
3.3.3 The US and China Have the Highest Share of Patent Filings Globally
3.3.4 South Asian Funding Agencies Prominent for Developing Nanostructured Liposome-based Drug Carriers
3.3.5 Targeted Drug Delivery Systems Can Replace Systemic Delivery Systems
3.4.1 Hydrogel Adopts a Diffusion Sensitive Model to Improve Drug Delivery Efficiency
3.4.2 Improving Bioavailability of Hydrogels has Been One of the Most Researched Areas
3.4.3 Steady Positive Patent Publication Trend Is Observed Since 2015
3.4.4 Funding in EU is Predominantly Focused on Scaling up the Production of Hydrogels and Improving Bioavailability
3.4.5 Hydrogels are Amongst Materials that Have the Highest Drug Loading Capacity
3.5.1 Liposomes are Among the Most Widely Adopted Drug Delivery Systems
3.5.2 Chinese Academy of Sciences has the Highest Number of Publications on Liposome-based Targeted Drug delivery
3.5.3 APAC is Observed to Have a Significant Commercialization Focus for Liposome-based Drug Delivery Systems
3.5.4 Dermal-based Vaccine Delivery Systems are Gaining Traction for Liposome Materials
3.5.5 Liposome-based Drug Delivery System Significantly Improves Efficiency of Existing Cancer Therapy
3.6.1 Dendrimers Possess Properties, Which Makes Them Potential Materials for Extensive Adoption
3.6.2 Chinese Academy of Sciences Leads as the Major Research Institute
3.6.3 The US is Leading in Patent Filings on Dendrimers
3.6.4 Significant Number of Projects Initiated Through Horizon 2020 Program
3.6.5 Dendrimers are Adopted as Drug Delivery Materials to Improve Efficiency of Therapeutic Components
4.1 Benchmarking Rubrics
4.2 Nanostructured Lipids are Observed to Have the Highest Adoption Potential
4.3 Nanostructured Lipids are the Most Promising Materials for Targeted Drug Delivery
5.1 Growth Opportunities: Tapping into Targeted Drug Delivery
5.2 Growth Opportunities: The Four Major Prospects
5.3 Strategic Imperatives: Critical Success Factors
5.4 Impact of COVID-19 on Emerging Materials for Drug Delivery R&D
6.1 Key Contacts
7.1 Benchmarking Matrix Data (Explained)
7.1 Benchmarking Matrix Data (Explained) (Contd.)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.